期刊文献+

不同剂量氯胺酮对抑郁大鼠海马脑源性神经营养因子和酪氨酸受体激酶B的影响 被引量:10

Effects of different doses of ketamine on brain-derived neurotrophic factor and tyrosine receptor kinase B in hippocampus in mentally depressed rats
原文传递
导出
摘要 目的探讨不同剂量氯胺酮对抑郁大鼠海马脑源性神经营养因子(BDNF)及酪氨酸受体激酶B(TrkB)的影响。方法雄性Wistar大鼠50只,体重180~220g,月龄2月,采用随机数字表法,将大鼠随机分为5组(n=10):对照组(C组)和不同剂量氯胺酮组(K1-4组)。采用强迫游泳实验建立抑郁大鼠模型。药物干预前1d大鼠强迫游泳15min,药物干预当日,分别腹腔注射生理盐水1.0ml(C组)、氯胺酮2.5mg/kg(K1组)、5.0mg/kg(K2组)、10.0mg/kg(K3组)、20.0mg/kg(K4组)。给药后30min将大鼠再次行强迫游泳实验,观察并记录不动时间。行为学测试后,取海马组织测定BDNF及TrkB的含量。结果与C组比较,K1-4组不动时间缩短,K组和I(4组海马BDNF、TrkB含量升高(P〈0.05);K1-4组随氯胺酮浓度升高,不动时间缩短(P〈0.05),与K1组或K2组比较,K1组和K4组海马BDNF、TrkB含量升高(P〈0.05)。结论氯胺酮可呈剂量依赖性地发挥抗抑郁作用,可能与增加大鼠海马BDNF和TrkB含量有关。 Objective To investigate the effects of different doses of ketamine on brain-derived neurotrophic factor (BDNF) and tyrosine receptor kinase B (TrkB) in the hippocampus in mentally depressed rats. Methods Fifty male Wistar rats weighing 180-220 g were randomly divided into 5 groups ( n = 10 each) : group control (group C) and groups K1-4 ketamine 2.5, 5.0, 10.0 and 20.0 mg/kg. On the 1st day the animals were forced to swim for 15 min. On the 2nd day ketamine 2.5, 5.0, 10.0 and 20.0 mg/kg were given intraperitoneally in groups K1-4 respectively at 30 min after administration. The immobility time of the rats during the forced swimming test was recorded. The animals were then decapitated. The hippocampus was harvested for determination of BDNF and TrkB levels. Results Ketamine significantly decreased the immobility time during forced swimming test in a dose-dependent manner. The BDNF and TrkB levels in the hippocampus were significantly increased in K3 and K4 groups as compared with group C, and K1 and K2 groups. Conclusion The increased levels of BDNF and TrkB in the hippocampus are involved in the dose-dependent antidepressant effect of ketamine.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2011年第4期460-462,共3页 Chinese Journal of Anesthesiology
基金 国家自然科学基金(NO.30872424) 全军“十二五”医药卫生科研基金
关键词 氯胺酮 抑郁症 脑源性神经营养因子 受体蛋白质酪氨酸激酶类 Ketamine Depressive disorder Brain-derived neurotrophic factor Receptor proteintyrosine kinases
  • 相关文献

参考文献8

  • 1Zarate CA Jr,Singh JB,Carlson PJ,et al.A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.Arch Gen Psychiatry,2006,63(8):856-864.
  • 2Machado-Vieira R,Salvadore G,Diazganados N,et al.Ketamine and the next generation of antidepressants with a rapid onset of action.Pharmacol Ther,2009,123(2):143-150.
  • 3Li N,Lee B,Liu RJ,et al.mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.Science,2010,329(5994):959-964.
  • 4李则挚,洪武,方贻儒.脑源性神经营养因子在抑郁症发作病理机制中的作用[J].上海交通大学学报(医学版),2010,30(6):651-655. 被引量:19
  • 5Kozisek ME,Middlemas D,Bylund DB.Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.Pharmacol Hier,2008,117(1):30-51.
  • 6Dwivedi Y,Rizavi HS,Conley RR,et al.Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects.Arch Gen Psychiatry,2003,60(8):804-815.
  • 7Detke MJ,Rickels M,Lucki I.Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants.Psychophannacology (Berl),1995,121(1):66-72.
  • 8高东,韩明飞,蒋晓江,孙学礼.慢性强迫游泳应激对大鼠海马神经元再生和p-CREB表达的影响[J].神经疾病与精神卫生,2010(4):329-331. 被引量:3

二级参考文献47

  • 1Kessler RC,Berglund P,Demler O,et al.The epidemiology of major depressive disorder:results from the National Comorbidity Survey Replication[J].JAMA,2003,289(23):3095-3105.
  • 2Malcangio M,Lessmann V.A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors[J].Trends Pharmacol Sci,2003,24(3):116-121.
  • 3Kiss JP.Theory of active antidepressants:a nonsynaptic approach to the treatment of depression[J].Neurochem Int,2008,52(1-2):34-39.
  • 4Trown J,Cooper-Kuhn CM,Kempermann G,et al.Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis[J].Eur J Neurosci,2003,17(10):2042-2046.
  • 5Tsankova NM,Berton O,Renthal W,et al.Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action[J].Nat Neurosci,2006,9(4):519-525.
  • 6Greenwood BN,Strong PV,Foley TE,et al.Learned helplessness is independent of levels of brain-derived neurotrophic factor in the hippocampus[J].Neuroscience,2007,144(4):1193-1208.
  • 7Schaaf MJ,De Kloet ER,Vreugdenhil E.Corticosterone effects on BDNF expression in the hippocampus.Implications for memory formation[J].Stress,2000,3(3):201-208.
  • 8Duman RS,Monteggia LM.A neurotrophic model for stress-related mood disorders[J].Biol Psychiatry,2006,59(12):1116-1127.
  • 9Czéh B,Lucassen PJ.What causes the hippocampal volume decrease in depression[J] ? Eur Arch Psychiatry Clin Neurosci,2007,257(5):250-260.
  • 10McEwen BS.Possible mechanisms for atrophy of the human hippocampus[J].Mol Psychiatry,1997,2(3):255-262.

共引文献20

同被引文献94

  • 1Woolley SB, Fredman L, Goethe JW, et al. Hospital patients' perceptions during treatment and early discontinuation of serotonin selective reuptake inhibitor antidepressants [J]. J Clin Psychopharmacol, 2010, 30(6): 716-719.
  • 2Martin A, Kaufman J, Charney D. Pharmacotherapy of early-onset depression. Update and new directions [J]. Child Adolesc Psychiatr Clin N Am, 2000, 9(1): 135-157.
  • 3Li N, Lee B, Liu RJ, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists [J]. Science, 2010, 329(5994): 959-964.
  • 4Zarate CA Jr, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression [J]. Arch Gen Psychiatry, 2006, 63(8): 856-864.
  • 5Furukawa-Hibi Y, Nitta A, Ikeda T, et al. The hydrophobic dipeptide Leu-Ile inhibits immobility induced by repeated forced swimming via the induction of BDNF[J]. Behav Brain Res, 2011, 220(2): 271-280.
  • 6Machado-Vieira R, Salvadore G, Diazgranados N, et al. Ketamine and the next generation of antidepressants with a rapid onset of action [J]. Pharmacol Ther, 2009, 123(2): 143-150.
  • 7Skolnick P, Popik P, Trullas R. Glutamate-based antidepressants: 20 years on[J]. Trends Pharmacol Sci, 2009, 30(11): 563-569.
  • 8Haller J, Nagy R, Toth M, et al. NR2B subunit-specific NMDA antagonist Ro25-6981 inhibits the expression of conditioned fear: a comparison with the NMDA antagonist MK-801 and fluoxetine [J]. Behav Pharmacol, 2011, 22(2): 113-121.
  • 9Wang J, Goffer Y, Xu D, et al. A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats[J]. Anesthesiology, 2011, 115(4): 812-821.
  • 10Skolnick P, Popik P, Trullas R. Glutamate-based antidepressants: 20 years on. Trends Pharmacol Sci, 2009, 309(11) : 563-569.

引证文献10

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部